IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K306. A total of 106 filers reported holding IDERA PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.26 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $66,000 | -31.2% | 49,952 | -4.5% | 0.00% | – |
Q1 2018 | $96,000 | +11.6% | 52,281 | +28.7% | 0.00% | – |
Q4 2017 | $86,000 | -46.9% | 40,622 | -44.0% | 0.00% | – |
Q3 2017 | $162,000 | +305.0% | 72,576 | +211.4% | 0.00% | – |
Q2 2017 | $40,000 | -7.0% | 23,307 | +35.3% | 0.00% | – |
Q1 2017 | $43,000 | -36.8% | 17,221 | -61.9% | 0.00% | – |
Q4 2016 | $68,000 | -18.1% | 45,197 | +38.9% | 0.00% | – |
Q3 2016 | $83,000 | +43.1% | 32,544 | -14.5% | 0.00% | – |
Q2 2016 | $58,000 | +163.6% | 38,052 | +233.1% | 0.00% | – |
Q1 2016 | $22,000 | -93.9% | 11,423 | -90.2% | 0.00% | – |
Q4 2015 | $360,000 | -23.7% | 116,480 | -17.4% | 0.00% | -100.0% |
Q3 2015 | $472,000 | -32.1% | 140,979 | -24.7% | 0.00% | 0.0% |
Q2 2015 | $695,000 | +157.4% | 187,177 | +157.6% | 0.00% | – |
Q1 2015 | $270,000 | -27.4% | 72,675 | -13.9% | 0.00% | – |
Q4 2014 | $372,000 | +1140.0% | 84,378 | +533.3% | 0.00% | – |
Q3 2014 | $30,000 | -85.7% | 13,324 | -81.6% | 0.00% | – |
Q2 2014 | $210,000 | -80.6% | 72,421 | -72.7% | 0.00% | -100.0% |
Q1 2014 | $1,084,000 | +867.9% | 265,613 | +1001.3% | 0.00% | – |
Q4 2013 | $112,000 | – | 24,118 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Virtus ETF Advisers LLC | 474,609 | $626,000 | 0.55% |
Kassirer Asset Management Corp | 325,800 | $430,000 | 0.28% |
CORRADO ADVISORS, LLC | 104,850 | $138,000 | 0.08% |
Artal Group S.A. | 2,750,000 | $3,630,000 | 0.08% |
ROPES WEALTH ADVISORS LLC | 100,000 | $132,000 | 0.04% |
MYCIO WEALTH PARTNERS, LLC | 246,527 | $325,000 | 0.03% |
Palo Alto Investors LP | 616,355 | $814,000 | 0.03% |
HOLLENCREST CAPITAL MANAGEMENT | 172,570 | $228,000 | 0.03% |
LAU ASSOCIATES LLC | 26,713 | $35,000 | 0.02% |
NATIXIS | 3,438,529 | $4,539,000 | 0.02% |